» Articles » PMID: 7679504

5' Control Regions of the Apolipoprotein(a) Gene and Members of the Related Plasminogen Gene Family

Overview
Specialty Science
Date 1993 Feb 15
PMID 7679504
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated blood levels of apolipoprotein(a), the component of lipoprotein(a) that distinguishes it from low density lipoprotein, are a major risk factor for atherosclerosis. The apolipoprotein(a) gene is highly similar to the plasminogen gene and to at least four other genes or pseudogenes. The 5' untranslated and flanking sequences of these six genes contain extensive regions of near identity and share sequence elements involved in the initiation of transcription and translation. About 1000 base pairs of flanking DNA of each gene are sufficient to promote transcription in cultured hepatocytes. The apolipoprotein(a) gene promoter contains functional interleukin 6-responsive elements, consistent with the reported acute-phase response of apolipoprotein(a). Flanking genomic fragments of the apoliprotein(a) gene from two individuals with vastly different plasma apolipoprotein(a) concentrations have sequence differences that are reflected in differences in the rate of in vitro transcription.

Citing Articles

Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues.

Konieczynska M, Natorska J, Zabczyk M, Undas A Arch Med Sci. 2025; 20(6):1770-1783.

PMID: 39967936 PMC: 11831339. DOI: 10.5114/aoms/197357.


Lipoprotein(a) and cardiovascular disease.

Boffa M, Koschinsky M Biochem J. 2024; 481(19):1277-1296.

PMID: 39302109 PMC: 11555715. DOI: 10.1042/BCJ20240037.


Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk.

Harb T, Ziogos E, Blumenthal R, Gerstenblith G, Leucker T Eur Heart J Open. 2024; 4(5):oeae064.

PMID: 39219855 PMC: 11365507. DOI: 10.1093/ehjopen/oeae064.


Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review.

Zubiran R, Neufeld E, Dasseux A, Remaley A, Sorokin A Cardiol Ther. 2024; 13(3):465-491.

PMID: 39031302 PMC: 11333429. DOI: 10.1007/s40119-024-00376-3.


Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.

Volgman A, Koschinsky M, Mehta A, Rosenson R J Am Heart Assoc. 2024; 13(12):e033654.

PMID: 38879448 PMC: 11255763. DOI: 10.1161/JAHA.123.033654.


References
1.
Malinowski D, Sadler J, Davie E . Characterization of a complementary deoxyribonucleic acid coding for human and bovine plasminogen. Biochemistry. 1984; 23(18):4243-50. DOI: 10.1021/bi00313a035. View

2.
Sandholzer C, Saha N, Kark J, Rees A, Jaross W, Dieplinger H . Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb. 1992; 12(10):1214-26. DOI: 10.1161/01.atv.12.10.1214. View

3.
Rhoads G, Dahlen G, Berg K, Morton N, Dannenberg A . Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986; 256(18):2540-4. View

4.
Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

5.
Krempler F, Kostner G, Bolzano K, SANDHOFER F . Turnover of lipoprotein (a) in man. J Clin Invest. 1980; 65(6):1483-90. PMC: 371487. DOI: 10.1172/JCI109813. View